Vertex Pharmaceuticals (VRTX) Cost of Revenue & History | Stock Alarm

Demo Sign up Log In

Vertex Pharmaceuticals · Cost of Revenue

VRTX Cost of Revenue

Latest reported$1.76Bperiod endingJun 30, 2026

VRTX Cost of Revenue ($0.00 → $1.76B)

Annual cost of revenue

High-resolution chart · PNG

VRTX cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	1,807,100,000
Dec 31, 2024	1,530,500,000
Dec 31, 2023	1,262,200,000
Dec 31, 2022	1,080,300,000
Dec 31, 2021	904,200,000
Dec 31, 2020	736,300,000
Dec 31, 2019	547,758,000
Dec 31, 2018	409,539,000
Dec 31, 2017	275,119,000
Dec 31, 2016	210,460,000
Dec 31, 2015	125,542,000
Dec 31, 2014	60,987,000
Dec 31, 2013	130,277,000
Dec 31, 2012	279,885,000
Dec 31, 2011	80,505,000
Dec 31, 2010	12,730,000
Dec 31, 2009	14,202,000
Dec 31, 2008	15,686,000
Dec 31, 2007	13,904,000
Dec 31, 2006	12,170,000
Dec 31, 2005	10,098,000
Dec 31, 2004	5,649,000
Dec 31, 2003	3,126,000
Dec 31, 2002	28,281,000
Dec 31, 2001	39,629,000
Dec 31, 2000	4,082,000
Dec 31, 1999	-3,400,000
Dec 31, 1998	-4,500,000
Dec 31, 1997	-3,600,000
Dec 31, 1996	-3,200,000
Dec 31, 1995	-3,700,000
Dec 31, 1994	-3,500,000
Dec 31, 1993	-3,900,000
Dec 31, 1992	-2,800,000
Dec 31, 1991	-1,800,000
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.